EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C20H19N3O |
| Net Charge | 0 |
| Average Mass | 317.392 |
| Monoisotopic Mass | 317.15281 |
| SMILES | O=C1c2ccccc2N[C@@H](c2cnc3ccccc23)[C@@H]2CCCN12 |
| InChI | InChI=1S/C20H19N3O/c24-20-14-7-2-4-9-17(14)22-19(18-10-5-11-23(18)20)15-12-21-16-8-3-1-6-13(15)16/h1-4,6-9,12,18-19,21-22H,5,10-11H2/t18-,19-/m0/s1 |
| InChIKey | CAWZYUQNVABYFN-OALUTQOASA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Xenorhabdus eapokensis (ncbitaxon:1873482) | - | PubMed (29596433) |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 9-deoxy tilivalline (CHEBI:219985) is a benzodiazepine (CHEBI:22720) |
| IUPAC Name |
|---|
| (6S,6aS)-6-(1H-indol-3-yl)-5,6,6a,7,8,9-hexahydropyrrolo[2,1-c][1,4]benzodiazepin-11-one |
| Manual Xrefs | Databases |
|---|---|
| 78442856 | ChemSpider |